Young Investigator Award 2021

Antimicrobial Resistance (AMR) is a major public health issue worldwide. The Institut Mérieux and its entities have been committed for many years in the fight against AMR and the improvement of antibiotic stewardship. Over the last year, COVID-19 has disrupted

In order to provide an incentive for promising young investigators working in the field of AMR and COVID-19, Institut Mérieux wishes to allocate several awards worldwide to researchers or clinicians at the beginning of their carrier in recognition of a major achievement having a significant impact on the handling of AMR and/or infectious disease diagnostics or management.

To maximize the visibility of such an award, and ensure proper selection of the candidates, Institut Mérieux relies on the expertise of well-established organizations working in the field of infectious diseases in each selected country.

Institut Mérieux and KAVI Institute of Clinical Research, University of Nairobi, have decided to allocate in 2021 a joint Young Investigator Award of € 10,000, that will be given to the laureate during UoN-KNH Joint International Conference on Health on 27th October 2021.


Selection criteria

  • Serving in a hospital or in a relevant research institution as infectious disease clinician, clinical or molecular microbiologist, epidemiologist, pharmacist or laboratory scientist.
  • With less than 15 years of clinical practice experience or less than 10 years of working experience in microbiology after their postgraduate qualification.
  • Involved and made a significant contributions to infectious disease diagnostics, AMR or Covid-19 research and/or patient management with a national impact.
  • Indicators of impact could be either publication(s) in prominent international journals and/ or implementation of guidelines / protocols having led to significant improvements in the following areas.
    • Antimicrobial Resistance control.
    • Development of new tools / approach in controlling antimicrobial resistance.
    • Adoption of an innovative approach in patient management for controlling antimicrobial resistance or Covid-19
    • Any actions having led to improved control / reduction of hospital acquired infection rate.
    • Conduct of research that has guided policy or practice in diagnosis, treatment or control of Covid-19

Selection process and Conditions.

  • Applications for the award should reach KAVI-ICR on or before 30th June 2021
  • For the award, please submit the following through email to (see attached application form).
    • Full name of nominee and contact information (email address and cellphone number)
    • A brief CV of Nominee (3 pages maximum) detailing the professional history of the nominee, including a list of maximum 15 publications.
    • Two-page description of research and / or clinical projects the young researcher has performed which could be considered for the award. Attaching substantiating evidence such as publication of the nominees work is encouraged.
    • Three pages description of ongoing and future research undertaken by the applicant in the field of AMR and/or infectious disease diagnostics
    • A recommendation letter from the host institution where the nominee is working at the time of application.


  • Members of The Selection Committee at KAVI-Institute of Clinical Research will assess the applications and choose two to three suitable applications, which will be forwarded to the scientific board of Institut Mérieux with their recommendations for the selection of the laureate.  The Institut Mérieux keeps the possibility not to allocate any award if none of the proposal is meeting minimum qualification for the award.
  • Institut Mérieux will notify KAVI-ICR the name of the laureate for the year 2021. KAVI-ICR will organize an award ceremony during the International Conference on Health to be held in 27th October, 2021.
  • The amount for this award is ten thousand euros (€10,000). The award money will be transferred from Institut Mérieux to KAVI-ICR and the institute will hold responsibility for proper utilization of the fund for research by the laureate.